Format

Send to

Choose Destination
J Eur Acad Dermatol Venereol. 2014 Aug;28(8):1127-9. doi: 10.1111/jdv.12343. Epub 2013 Dec 13.

Secukinumab improves the signs and symptoms of moderate-to-severe plaque psoriasis in subjects with involvement of hands and/or feet: subanalysis of a randomized, double-blind, placebo-controlled, phase 2 dose-ranging study.

Author information

1
Faculty of Medicine, Department of Dermatology, University of Iceland, Reykjavik, Iceland.
PMID:
24330415
DOI:
10.1111/jdv.12343
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center